Indefinite Delivery Contract SPE2DB24D9210

DMS Pharmaceutical Group Inc., a woman-owned small business, was awarded a single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999 by the Defense Logistics Agency (DLA). The contract, number 4600082063, is for the procurement of a broad range of pharmaceutical products to fulfill the recurring medical supply needs of military health facilities supported by DLA worldwide. Products include tablets, capsules, injections, creams, solutions, and other drug forms spanning therapeutic categories such as antibiotics, anesthetics, contraceptives, and chemotherapies. This IDC complements DMS Pharmaceutical Group's existing prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense sites. As a woman-owned small business, DMS Pharmaceutical Group's contract status has enabled direct awards for pharmaceutical Prime Vendor programs supporting military medical facilities globally. The contract has a period of performance through December 31, 2025, allowing DLA to issue firm fixed-price delivery orders against the vehicle as needed.